Cliff Asness's AXSM Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 103,418 shares of Axsome Therapeutics, Inc. (AXSM) worth $18.89 M, representing 0.01% of the portfolio. First purchased in 2019-Q3, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AXSM, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 69,454 shares. Largest reduction occurred in Q2 2024, reducing 15,440 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Axsome Therapeutics (AXSM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Axsome Therapeutics (AXSM) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -15,238 | Reduce 12.84% | 103,418 | $182.64 |
| Q3 2025 | -9,161 | Reduce 7.17% | 118,656 | $121.45 |
| Q2 2025 | +69,454 | Add 119.00% | 127,817 | $104.39 |
| Q1 2025 | +20,152 | Add 52.74% | 58,363 | $116.63 |
| Q4 2024 | +11,049 | Add 40.68% | 38,211 | $84.61 |
| Q3 2024 | +14,326 | Add 111.61% | 27,162 | $89.87 |
| Q2 2024 | -15,440 | Reduce 54.60% | 12,836 | $80.50 |
| Q1 2024 | +19,946 | Add 239.45% | 28,276 | $79.80 |
| Q4 2023 | -1,431 | Reduce 14.66% | 8,330 | $79.59 |
| Q3 2023 | -1,946 | Reduce 16.62% | 9,761 | $69.89 |
| Q2 2023 | +2,882 | Add 32.66% | 11,707 | $71.86 |
| Q1 2023 | +148 | Add 1.71% | 8,825 | $61.68 |
| Q4 2022 | -3,108 | Reduce 26.37% | 8,677 | $77.13 |
| Q3 2022 | +6,089 | Add 106.90% | 11,785 | $44.63 |
| Q2 2022 | +5,696 | New Buy | 5,696 | $38.27 |
| Q1 2021 | -6,774 | Sold Out | 0 | $0.00 |
| Q4 2020 | -7,231 | Reduce 51.63% | 6,774 | $81.49 |
| Q3 2020 | -3,750 | Reduce 21.12% | 14,005 | $71.26 |
| Q2 2020 | -3,630 | Reduce 16.97% | 17,755 | $82.29 |
| Q1 2020 | -6,480 | Reduce 23.25% | 21,385 | $58.83 |
| Q4 2019 | +8,277 | Add 42.26% | 27,865 | $103.36 |
| Q3 2019 | +19,588 | New Buy | 19,588 | $20.22 |
Cliff Asness's Axsome Therapeutics Investment FAQs
Cliff Asness first purchased Axsome Therapeutics, Inc. (AXSM) in Q3 2019, acquiring 19,588 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Axsome Therapeutics, Inc. (AXSM) for 22 quarters since Q3 2019.
Cliff Asness's largest addition to Axsome Therapeutics, Inc. (AXSM) was in Q2 2025, adding 127,817 shares worth $13.34 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 103,418 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $18.89 M.
As of the Q4 2025 filing, Axsome Therapeutics, Inc. (AXSM) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Axsome Therapeutics, Inc. (AXSM) was 127,817 shares, as reported at the end of Q2 2025.